ProfileGDS4718 / 227416_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 85% 83% 91% 83% 84% 89% 87% 85% 83% 84% 84% 86% 86% 87% 88% 86% 85% 86% 90% 91% 81% 83% 85% 86% 83% 88% 85% 87% 85% 89% 87% 85% 83% 83% 87% 90% 90% 85% 83% 90% 85% 87% 88% 83% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]8.4903685
GSM549102patient 115, normal, homogenized [OPG study]8.1018883
GSM549104patient 119, normal, homogenized [OPG study]9.3803891
GSM549108patient 138, normal, homogenized [OPG study]8.1000283
GSM549119patient 077, normal, homogenized [OPG study]8.3473584
GSM549133patient 032, cancer, homogenized [OPG study]9.1167689
GSM549139patient 042, cancer, homogenized [OPG study]8.7151387
GSM549099patient 107, normal, homogenized [OPG study]8.411485
GSM549109patient 139, normal, homogenized [OPG study]8.138583
GSM549110patient 046, normal, homogenized [OPG study]8.3144984
GSM549114patient 063, normal, homogenized [OPG study]8.4711184
GSM549122patient 082, normal, homogenized [OPG study]8.6424786
GSM549134patient 033, cancer, homogenized [OPG study]8.5743786
GSM549136patient 036, cancer, homogenized [OPG study]8.7938687
GSM549140patient 044, cancer, homogenized [OPG study]8.8943388
GSM549111patient 047, normal, homogenized [OPG study]8.6358886
GSM549113patient 057, normal, homogenized [OPG study]8.5599985
GSM549132patient 031, cancer, homogenized [OPG study]8.5999986
GSM549137patient 038, cancer, homogenized [OPG study]9.0833790
GSM549142patient 047, cancer, homogenized [OPG study]8.9161591
GSM549100patient 110, normal, homogenized [OPG study]7.9087681
GSM549107patient 135, normal, homogenized [OPG study]8.2354383
GSM549115patient 068, normal, homogenized [OPG study]8.6120485
GSM549116patient 072, normal, homogenized [OPG study]8.6311986
GSM549120patient 078, normal, homogenized [OPG study]8.2267583
GSM549131patient 030, cancer, homogenized [OPG study]9.0310588
GSM549118patient 074, normal, homogenized [OPG study]8.5012585
GSM549129patient 027, cancer, homogenized [OPG study]8.6590987
GSM549123patient 088, normal, homogenized [OPG study]8.4588685
GSM549124patient 006, cancer, homogenized [OPG study]8.9157789
GSM549126patient 015, cancer, homogenized [OPG study]8.7062587
GSM549128patient 025, cancer, homogenized [OPG study]8.4885785
GSM549103patient 117, normal, homogenized [OPG study]8.0698583
GSM549117patient 073, normal, homogenized [OPG study]8.239183
GSM549138patient 041, cancer, homogenized [OPG study]8.8099687
GSM549141patient 045, cancer, homogenized [OPG study]9.2688690
GSM549130patient 028, cancer, homogenized [OPG study]9.1025390
GSM549101patient 111, normal, homogenized [OPG study]8.3663985
GSM549105patient 128, normal, homogenized [OPG study]8.2033783
GSM549106patient 134, normal, homogenized [OPG study]9.3684290
GSM549112patient 048, normal, homogenized [OPG study]8.4713385
GSM549125patient 011, cancer, homogenized [OPG study]8.6778287
GSM549127patient 024, cancer, homogenized [OPG study]8.8844588
GSM549135patient 035, cancer, homogenized [OPG study]8.3599183